DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Murthy R, Borges VF, Conlin A. et al.
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.
Lancet Oncol 2018;
19: 880-888
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.